3D Rotational CT Angiogram With Embolization Guidance and CBCT in Prostatic Artery Embolization
NCT ID: NCT03164629
Last Updated: 2019-06-11
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2017-04-17
2018-10-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ASCVD Management Using CCTA in Prostate Cancer Patients on ADT
NCT05879913
CT/MRI Co-registration Prostate Cancer
NCT00252460
Neoadjuvant Embolization and Cytoreduction in Prostate Cancer
NCT07251829
Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization
NCT04879940
Cone Beam CT for Daily Image Guidance - Prostate Cancer
NCT00188786
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
3D Angiogram + Emboguide
Participants will receive cone-beam CT 3D Emboguide: cone-beam CT with Embolization Guidance software (Emboguide) to identify prostatic arteries and assist endovascular navigation, by projecting a 3D road map of prostatic arteries on live fluoroscopy, in order to differentiate them from non-target vessels.
cone-beam CT 3D Emboguide
cone-beam CT with Embolization Guidance software (Emboguide) to identify prostatic arteries and assist endovascular navigation, by projecting a 3D road map of prostatic arteries on live fluoroscopy, in order to differentiate them from non-target vessels.
No 3D Angiogram + Emboguide
Embolization will be guided by a standard of care CT.
cone-beam CT 3D Emboguide
cone-beam CT with Embolization Guidance software (Emboguide) to identify prostatic arteries and assist endovascular navigation, by projecting a 3D road map of prostatic arteries on live fluoroscopy, in order to differentiate them from non-target vessels.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cone-beam CT 3D Emboguide
cone-beam CT with Embolization Guidance software (Emboguide) to identify prostatic arteries and assist endovascular navigation, by projecting a 3D road map of prostatic arteries on live fluoroscopy, in order to differentiate them from non-target vessels.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients undergoing Prostate artery embolization for BPH or urinary retention -Patient has signed informed consent.
Exclusion Criteria
* Patient weight of \>300 lbs
50 Years
79 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Siemens Corporation, Corporate Technology
INDUSTRY
University of Miami
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shivank Bhatia
Assistant Professor of Clinical Radiology & Urology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shivank Bhatia
Role: PRINCIPAL_INVESTIGATOR
University of Miami
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Professional Arts Center
Miami, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20160589
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.